Possibilities of using high-intensity focused ultrasound therapy in patients with endometriosis

DOI

https://dx.doi.org/10.18565/aig.2021.1.19-26

Moskvicheva L.I.
P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Currently, endometriosis remains one of the most common gynecological diseases in reproductive-aged women, which leads to a decrease in their quality of life and performance due to the development of the phenomena of dysmenorrhea, menorrhagia, dyspareunia, severe pelvic pain syndrome, and infertility. The main treatments for this disease are medical therapy associated with a high number of complications, as well as surgical therapy characterized by surgical trauma and a significant relapse rate for the disease. In this connection, it is relevant to develop and introduce new endometriosis treatments into wide practice, which have a high efficiency, locality of exposure, and no effect on the hormonal status of patients, allowing them to restore their working capacity and lost reproductive function. High-intensity focused ultrasound (HIFU) therapy, a non-invasive local thermal exposure technique used to treat a number of benign and malignant diseases of different organs, is currently considered as one of these options. The aim of this study is to review literature on the possibilities of using this ablation method in patients with endometriosis.
Conclusion. HIFU therapy has a significant number of clinical and technical limitations; however, its high therapeutic effectiveness, safety, and economic efficiency give it a clear advantage over traditional methods for treating this disease and contribute to the growth of researchers’ interest in the described topic and to the wider introduction of ultrasound ablation into clinical practice.

endometriosis

adenomyosis

anterior abdominal wall endometriosis

high-intensity focused ultrasound therapy

HIFU

thermal ablation

Full text (in Russian)

Tanbo T., Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet. Gynecol. Scand. 2017; 96(6): 659-67. https://dx.doi.org/10.1111/aogs.13082.
Laganà A.S., Garzon S., Götte M., Viganò P., Franchi M., Ghezzi F., Martin D.C. The pathogenesis of endometriosis: molecular and cell biology insights. Int. J. Mol. Sci. 2019; 20(22): 5615. https://dx.doi.org/10.3390/ijms20225615.
Guo S.W. Recurrence of endometriosis and its control. Hum. Reprod. Update. 2009; 15(4): 441-61. https://dx.doi.org/10.1093/humupd/dmp007.
Taran F.A., Stewart E.A., Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd. 2013; 73(9): 924-31. https://dx.doi.org/10.1055/s-0033-1350840.
Dessouky R., Gamil S.A., Nada M.G., Mousa R., Libda Y. Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy. Insights Imaging. 2019; 10(1): 48. https://dx.doi.org/10.1186/s13244-019-0732-8.
Maresca D., Lakshmanan A., Abedi M., Bar-Zion A., Farhadi A., Lu G.J. et al. Biomolecular ultrasound and sonogenetics. Annu. Rev. Chem. Biomol. Eng. 2018; 9: 229-52. https://dx.doi.org/10.1146/annurev-chembioeng-060817-084034
van den Bijgaart R.J.E., Eikelenboom D.C., Hoogenboom M., Fütterer J.J., den Brok M.H., Adema G.J. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. Cancer Immunol. Immunother. 2017; 66(2): 247-58. https://dx.doi.org/10.1007/s00262-016-1891-9.
Shi G., Zhong M., Ye F., Zhang X. Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities. Cancer Biol. Med. 2019; 16(4): 714-28. https://dx.doi.org/10.20892/j.issn.2095-3941.2019.0232.
Siedek F., Yeo S.Y., Heijman E., Grinstein O., Bratke G., Heneweer C. et al. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU): technical background and overview of current clinical applications (Part 1). Rofo. 2019; 191(6): 522-30. https://dx.doi.org/10.1055/a-0817-5645.
Москвичева Л.И. Высокоинтенсивная фокусированная ультразвуковая абляция злокачественных новообразований молочной железы. Исследования и практика в медицине. 2018; 5(3): 67-76. [Moskvicheva L.I. High-intensity focused ultrasonic ablation of breast cancer. Research and Practical Medicine Journal. 2018; 5(3): 67-76. (in Russian)]. https://dx.doi.org/10.17709/2409-2231-2018-5-3-6.
Li S., Wu P.-H. Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer. Chin. J. Cancer. 2013; 32(8): 441-52. https://dx.doi.org/10.5732/cjc.012.10104.
Cain-Nielsen A.H., Moriarty J.P., Stewart E.A., Borah B.J. Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA. J. Comp. Eff. Res. 2014; 3(5): 503-14. https://dx.doi.org/10.2217/cer.14.32.
Elhelf I.A.S., Albahar H., Shah U., Oto A., Cressman E., Almekkawy M. High intensity focused ultrasound: The fundamentals, clinical applications and research trends. Diagn. Interv. Imaging. 2018; 99(6): 349-59. https://dx.doi.org/10.1016/j.diii.2018.03.001.
Clark N.A., Mumford S.L., Segars J.H. Reproductive impact of MRI-guided focused ultrasound surgery for fibroids: a systematic review of the evidence. Curr. Opin. Obstet. Gynecol. 2014; 26(3): 151-61. https://dx.doi.org/10.1097/GCO.0000000000000070.
Yang Z., Cao Y.D., Hu L.N., Wang Z.B. Feasibility of laparoscopic high-intensity focused ultrasound treatment for patients with uterine localized adenomyosis. Fertil. Steril. 2009; 91(6): 2338-43. https://dx.doi.org/10.1016/j.fertnstert.2008.03.017.
Zhang L., Rao F., Setzen R. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility. Acta Obstet. Gynecol. Scand. 2017; 96(6): 707-14. https://dx.doi.org/10.1111/aogs.13159.
Zhang L., Zhang W., Orsi F., Chen W., Wang Z. Ultrasound guided high intensity focused ultrasound for the treatment of gynaecological conditions: a review of safety and efficacy. Int. J. Hyperthermia. 2015; 31(3): 280-4. https://dx.doi.org/10.3109/02656736.2014.996790.
Dev B., Gadddam S., Kumar M., Varadarajan S. MR-guided focused ultrasound surgery: A novel non-invasive technique in the treatment of adenomyosis -18 month’s follow-up of 12 cases. Indian J. Radiol. Imaging. 2019; 29(3): 284-8. https://dx.doi.org/10.4103/ijri.IJRI_53_19.
Xiong Y., Yue Y., Shui L., Orsi F., He J., Zhang L. Ultrasound guided high intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: a retrospective study. Int. J. Hyperthermia. 2015; 31(7): 777-83. https://dx.doi.org/10.3109/02656736.2015.1071436.
Lee J.S., Hong G.Y., Park B.J., Kim T.E. Ultrasound guided high intensity focused ultrasound treatment for uterine fibroid and adenomyosis: a single center experience from the Republic of Korea. Ultrason. Sonochem. 2015; 27: 682-7. https://dx.doi.org/10.1016/j.ultsonch.2015.05.033.
Liu X., Wang W., Wang Y., Wang Y., Li Q., Tang J. Clinical predictors of long-term success in ultrasound-guided high intensity focused ultrasound ablation treatment for adenomyosis. Medicine (Baltimore). 2016; 95(3): e2443. https://dx.doi.org/10.1097/MD.0000000000002443.
Guo Y., Duan H., Cheng J., Zhang Y. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study. BJOG. 2017; 124(Suppl. 3): 7-11. https://dx.doi.org/10.1111/1471-0528.14736.
Hou Y., Qin Z., Fan K., Xu Y., Huang X. Combination therapeutic effects of high intensity focused ultrasound and Metformin for the treatment of adenomyosis. Exp. Ther. Med. 2018; 15(2): 2104-8. https://dx.doi.org/10.3892/etm.2017.5601.
Long L., Chen J., Xiong Y., Zou M., Deng Y., Chen L., Wang Z. Efficacy of high-intensity focused ultrasound ablation for adenomyosis therapy and sexual life quality. Int. J. Clin. Exp. Med. 2015; 8(7): 11701-7.
Gong C., Yang B., Shi Y., Liu Z., Wan L., Zhang H. et al. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: a retrospective study. Int. J. Hyperthermia. 2016; 32(5): 496-503. https://dx.doi.org/10.3109/02656736.2016.1149232.
Gong C., Setzen R., Liu Z., Liu Y., Xie B., Aili A., Zhang L. High intensity focused ultrasound treatment of adenomyosis: the relationship between the features of magnetic resonance imaging on T2 weighted images and the therapeutic efficacy. Eur. J. Radiol. 2017; 89: 117-22. https://dx.doi.org/10.1016/j.ejrad.2017.02.001.
Zhou C.Y., Xu X.J., He J. Pregnancy outcomes and symptom improvement of patients with adenomyosis treated with high intensity focused ultrasound ablation (in Chinese). Zhonghua Fu Chan Ke Za Zhi. 2016; 51(11): 845-9. https://dx.doi.org/10.3760/cma.j.issn.0529-567X.2016.11.009.
Liu X.F., Huang L.H., Zhang C., Huang G.H., Yan L.M., He J. A comparison of the cost-utility of ultrasound-guided high-intensity focused ultrasound and hysterectomy for adenomyosis: a retrospective study. BJOG. 2017; 124(Suppl. 3): 40-5. https://dx.doi.org/10.1111/1471-0528.14746.
Lopez-Soto A., Sanchez-Zapata M.I., Martinez-Cendan J.P., Ortiz Reina S., Bernal Mañas C.M., Remezal Solano M. Cutaneous endometriosis: Presentation of 33 cases and literature review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018; 221: 58-63. https://dx.doi.org/10.1016/j.ejogrb.2017.11.024.
Sedhain N., Dangal G., Karki A., Pradhan H.K., Shrestha R., Bhattachan K. et al. Caesarean scar endometriosis. J. Nepal Health Res. Counc. 2018; 15(3): 292-4. https://dx.doi.org/10.3126/jnhrc.v15i3.18859.
Wang Y., Wang W., Wang L., Wang J., Tang J. Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: preliminary results. Eur. J. Radiol. 2011; 79(1): 56-9. https://dx.doi.org/10.1016/j.ejrad.2009.12.034.
Zhu X., Chen L., Deng X., Xiao S., Ye M., Xue M. A comparison between high-intensity focused ultrasound and surgical treatment for the management of abdominal wall endometriosis. BJOG. 2017; 124(Suppl. 3): 53-8. https://dx.doi.org/10.1111/1471-0528.14737.
Zhang X., Duan H. Effect of high-intensity focused ultrasound ablation on endometriosis of the abdominal wall. Int. J. Clin. Exp. Pathol. 2018; 11(4): 2118-24.
Luo S., Zhang C., Huang J.P., Huang G.H., He J. Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: a retrospective study. BJOG. 2017; 124(Suppl. 3): 59-63. https://dx.doi.org/10.1111/1471-0528.14741.
Nguyen M.D. Magnetic resonance imaging-guided high-intensity focused ultrasound ablation for endometriosis of the abdominal wall. Gynecol. Minim. Invasive Ther. 2020; 9(1): 45-6. https://dx.doi.org/10.4103/GMIT.GMIT_47_19.

Received 22.07.2020

Accepted 22.09.2020

Liudmila I. Moskvicheva, oncologist of the Ultrasound Department, P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation. E-mail: ludamed16@mail.ru. ORCID: 0000-0002-5750-8492; SPIN: 8321-3464.
125284, Russia, Moscow, 2nd Botkinsky passage, 3.

For citation: Moskvicheva L.I. Possibilities of using high-intensity focused ultrasound therapy in patients with endometriosis.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2021; 1: 19-26 (in Russian)
https://dx.doi.org/10.18565/aig.2021.1.19-26

Possibilities of using high-intensity focused ultrasound therapy in patients with endometriosis

Moskvicheva L.I.

Keywords

References

About the Authors

Similar Articles